Related to pharmacotherapy (anti-obesity treatment) is to block pancreatic lipase, a pancreatic enzyme that separates triglycerides into mono acyl glycerol and free fatty acids to ease their absorption7. This evidence concerns the gene PNLIP and obesity due to melanocortin 4 receptor deficiency.